Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04005144
Title Brigatinib and Binimetinib in Treating Patients With Stage IIIB-IV ALK or ROS1-Rearranged Non-small Cell Lung Cancer
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors University of California, San Francisco

lung non-small cell carcinoma


Binimetinib + Brigatinib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST